Note: This is a project under development. The articles on this wiki are just being initiated and broadly incomplete. You can Help creating new pages.

Difference between revisions of "Kaiśora Guggulu"

From Ayurwiki
Jump to: navigation, search
 
Line 53: Line 53:
  
 
==Therapeutic uses==
 
==Therapeutic uses==
*Mandāgni (Dyspepsia), Vibandha (constipation), Vātaśnita (Gout), Pramehapidīkā (Diabetic carbuncle), Vrana (Ulcer), Kāsa (cough), Kuṣṭha (diseases of skin), Gulma (abdominal lump), Śvayathu (oedema), Pāndu (anaemia), Meha (excessive flow of urine), Jarādosha (geriatric disorder).
+
*Mandāgni (Dyspepsia), Vibandha (Constipation), Vātaśnita (Gout), Pramehapidīkā (Diabetic carbuncle), Vrana (Ulcer), Kāsa (Cough), Kuṣṭha (Diseases of skin), Gulma (Abdominal lump), Śvayathu (Oedema), Pāndu (Anaemia), Meha (Excessive flow of urine), Jarādosha (Geriatric disorder).
  
 
==Dose==
 
==Dose==
Line 84: Line 84:
  
 
[[Category:Formulations]]
 
[[Category:Formulations]]
 +
[[Category:Ayurvedic Medicine]]
 +
[[Category:Therapeutic use of Formula - Dyspepsia]]
 +
[[Category:Therapeutic use of Formula - Constipation]]
 +
[[Category:Therapeutic use of Formula - Gout]]
 +
[[Category:Therapeutic use of Formula - Diabetic carbuncle]]
 +
[[Category:Therapeutic use of Formula - Ulcer]]
 +
[[Category:Therapeutic use of Formula - Cough]]
 +
 +
[[Category:Therapeutic use of Formula - Diseases of skin]]
 +
[[Category:Therapeutic use of Formula - Abdominal lump]]
 +
[[Category:Therapeutic use of Formula - Oedema]]
 +
[[Category:Therapeutic use of Formula - Anaemia]]
 +
[[Category:Therapeutic use of Formula - Excessive flow of urine]]
 +
[[Category:Therapeutic use of Formula - Geriatric disorder]]

Latest revision as of 10:17, 20 September 2018

Kaiśora Guggulu is a vaṭī preparation made with the ingredients in the Formulation composition given below with Guggulu as the basic ingredient.

Formulation composition

Guggulu API- (Śuddha) Commiphora wighti Exd. 768 g
Harītakī API Terminalia chebula P. 256 g
Bibhītaka API Terminalia bellirica P. 256 g
Āmalakī API Phyllanthus emblica (Emblica officinalis) P. 256 g
Chinnaruhā (Guḍūcī API) Tinospora cordifolia St. 1.54 kg
Jala API for decoction Water 12.29 1
reduced to 6.14 1
Harītakī API Terminalia chebula P. 8 g
Bibhītaka API Terminalia bellirica P. 8 g
Āmalakī API Phyllanthus emblica P. 8 g
Śuṇṭhī API Zingiber officinale Rz. 24 g
Marica API Piper nigrum Fr. 24 g
Pippalī API Piper longum Fr. 24 g
Kṛmiripu (Viḍaṅga API ) Embelia ribes Fr. 24 g
Trivṛt API Operculina turpethum Rt. 12 g
Dantī API Baliospermum montanum Rt. 12 g
Amṛtā (Guḍūcī API ) Tinospora cordifolia St. 48 g
Ghṛta (Goghṛta API) Clarified butter from cow’s milk 384 g

Method of preparation

  • Take all ingredients of pharmacopoeial quality.
  • Wash, dry and powder the ingredients number 7 to 16 of the formulation compostion to a fine
  • powder separately and pass through sieve number 85.
  • Soak the coarse powder of ingredients 2 to 5 in potable water in the specified ratio for 1 hr, boil it till the volume is reduced to half of its original volume. Cool the kashaaya and filter through a muslin cloth[1]

Description

  • Spherical pills, dark brown in color with pleasant odour, taste astringent and sweetish.

Storage

  • Store in a cool place in tightly closed containers, protected from light and moisture.

Therapeutic uses

  • Mandāgni (Dyspepsia), Vibandha (Constipation), Vātaśnita (Gout), Pramehapidīkā (Diabetic carbuncle), Vrana (Ulcer), Kāsa (Cough), Kuṣṭha (Diseases of skin), Gulma (Abdominal lump), Śvayathu (Oedema), Pāndu (Anaemia), Meha (Excessive flow of urine), Jarādosha (Geriatric disorder).

Dose

  • 3 g daily in divided doses.

Anupāna

  • Mudga Yūsha, Milk, Sugandhijala.

Physico-chemical parameters

Loss on drying Not more than 13.0 per cent
Total ash Not more than 9.0 per cent
Acid-insoluble ash Not more than 2.0 per cent
Alcohol-soluble extractive Not less than 40.0 per cent
Water-soluble extractive Not less than 34.0
pH (1% aqueous solution) 4.0 to 4.5

References

  1. THE AYURVEDIC PHARMACOPOEIA OF INDIA, PART-II, VOLUME-1, page no 95.